Introduction
Autoimmune thyroid diseases, including Graves' disease (GD) and Hashimoto's thyroiditis (HT), are complex diseases in which a combination of genetic susceptibility and environmental encounters leads to breakdown of immune tolerance. Epidemiological and histological data indicate that thyroid cancer (TC) frequently occurs in the context of HT (Guarino et al. 2010) , and that the association between HT and TC is antibody specific (Azizi et al. 2014) . Several authors reported overexpression of claudin-1, protein of tight junctions, in invasive tumor cells, including TC, and it seems to be an early step in carcinogenesis for at least some cancer types. Natl Canc Inst., 24(4) 
R.M Abd El Atti, "Potential diagnostic utility of CD56 and claudin-1 in papillary thyroid carcinoma and solitary follicular thyroid nodules", J Egypt

Objectives
This study aimed to estimate expression of claudin-1 in the thyroid gland tissue of patients with HT and GD assessed by immunohistochemistry.
Results
Claudin-1 showed a circumferential membranous staining pattern in thyroid follicular epithelial cells, positive claudin-1 expression (staining in >5% of the cells) was observed in 27 out of 35 cases (77.1%). The highest claudin-1 mean expression level was observed in HT patients, although 6 out of 17 cases showed negative claudin-1 expression. The mean staining rate for claudin-1 in HT and GD thyroid follicular cells was calculated as 1.65±0.63 and 1.22±0.19, respectively, whereas in control group it was calculated as 1.58±0.44. Only 8 out of 35 cases (22.9%) showed claudin-1 positivity in >50% of the cells (score 4); six of which were HT and 2 were colloidals goiters. The number of claudin-1 immunopositive thyroid follicles in HT patients was significantly higher than that in control group p=0.030) .
Conclusions
These results demonstrate that HT and GD patients display different junction protein expression patterns. The overexpression of claudin-1 in HT when compared to control tissues and GD patients may be interpreted similarly to overexpression of claudins in epithelial-derived cancers, including TC, however, molecular mechanisms by which claudins affect tumorigenesis remain largely unknown.
